158 related articles for article (PubMed ID: 17284482)
1. Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function.
Chiellini G; Frascarelli S; Ghelardoni S; Carnicelli V; Tobias SC; DeBarber A; Brogioni S; Ronca-Testoni S; Cerbai E; Grandy DK; Scanlan TS; Zucchi R
FASEB J; 2007 May; 21(7):1597-608. PubMed ID: 17284482
[TBL] [Abstract][Full Text] [Related]
2. Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors.
Frascarelli S; Ghelardoni S; Chiellini G; Vargiu R; Ronca-Testoni S; Scanlan TS; Grandy DK; Zucchi R
Eur J Pharmacol; 2008 Jun; 587(1-3):231-6. PubMed ID: 18486124
[TBL] [Abstract][Full Text] [Related]
3. Tissue distribution and cardiac metabolism of 3-iodothyronamine.
Saba A; Chiellini G; Frascarelli S; Marchini M; Ghelardoni S; Raffaelli A; Tonacchera M; Vitti P; Scanlan TS; Zucchi R
Endocrinology; 2010 Oct; 151(10):5063-73. PubMed ID: 20739399
[TBL] [Abstract][Full Text] [Related]
4. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity.
Accorroni A; Rutigliano G; Sabatini M; Frascarelli S; Borsò M; Novelli E; Bandini L; Ghelardoni S; Saba A; Zucchi R; Origlia N
Thyroid; 2020 Jan; 30(1):147-160. PubMed ID: 31709926
[No Abstract] [Full Text] [Related]
5. 3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors.
Laurino A; Matucci R; Vistoli G; Raimondi L
Eur J Pharmacol; 2016 Dec; 793():35-42. PubMed ID: 27815171
[TBL] [Abstract][Full Text] [Related]
6. N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity.
Landucci E; Gencarelli M; Mazzantini C; Laurino A; Pellegrini-Giampietro DE; Raimondi L
Neurochem Int; 2019 Oct; 129():104460. PubMed ID: 31075293
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.
Warnecke C; Kaup D; Marienfeld U; Poller W; Yankah C; Gräfe M; Fleck E; Regitz-Zagrosek V
J Mol Med (Berl); 2001 Sep; 79(9):510-21. PubMed ID: 11692164
[TBL] [Abstract][Full Text] [Related]
8. 3-Iodothyronamine Induces Diverse Signaling Effects at Different Aminergic and Non-Aminergic G-Protein Coupled Receptors.
Biebermann H; Kleinau G
Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):395-400. PubMed ID: 31698479
[TBL] [Abstract][Full Text] [Related]
9. Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5.
Dinter J; Mühlhaus J; Wienchol CL; Yi CX; Nürnberg D; Morin S; Grüters A; Köhrle J; Schöneberg T; Tschöp M; Krude H; Kleinau G; Biebermann H
PLoS One; 2015; 10(2):e0117774. PubMed ID: 25706283
[TBL] [Abstract][Full Text] [Related]
10. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
[TBL] [Abstract][Full Text] [Related]
11. Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors.
Chiellini G; Erba P; Carnicelli V; Manfredi C; Frascarelli S; Ghelardoni S; Mariani G; Zucchi R
J Endocrinol; 2012 Jun; 213(3):223-30. PubMed ID: 22442117
[TBL] [Abstract][Full Text] [Related]
12. Uptake and metabolic effects of 3-iodothyronamine in hepatocytes.
Ghelardoni S; Chiellini G; Frascarelli S; Saba A; Zucchi R
J Endocrinol; 2014 Apr; 221(1):101-10. PubMed ID: 24627446
[TBL] [Abstract][Full Text] [Related]
13. 3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling.
Dinter J; Mühlhaus J; Jacobi SF; Wienchol CL; Cöster M; Meister J; Hoefig CS; Müller A; Köhrle J; Grüters A; Krude H; Mittag J; Schöneberg T; Kleinau G; Biebermann H
J Mol Endocrinol; 2015 Jun; 54(3):205-16. PubMed ID: 25878061
[TBL] [Abstract][Full Text] [Related]
14. In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine.
Laurino A; De Siena G; Saba A; Chiellini G; Landucci E; Zucchi R; Raimondi L
Eur J Pharmacol; 2015 Aug; 761():130-4. PubMed ID: 25941083
[TBL] [Abstract][Full Text] [Related]
15. Modulation of gene expression by 3-iodothyronamine: genetic evidence for a lipolytic pattern.
Mariotti V; Melissari E; Iofrida C; Righi M; Di Russo M; Donzelli R; Saba A; Frascarelli S; Chiellini G; Zucchi R; Pellegrini S
PLoS One; 2014; 9(11):e106923. PubMed ID: 25379707
[TBL] [Abstract][Full Text] [Related]
16. 3-Iodothyronamine and 3,5,3'-triiodo-L-thyronine reduce SIRT1 protein expression in the HepG2 cell line.
Sacripanti G; Lorenzini L; Bandini L; Frascarelli S; Zucchi R; Ghelardoni S
Horm Mol Biol Clin Investig; 2020 Mar; 41(1):. PubMed ID: 32114521
[TBL] [Abstract][Full Text] [Related]
17. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.
Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H
Front Pharmacol; 2018; 9():222. PubMed ID: 29593543
[TBL] [Abstract][Full Text] [Related]
18. Determination of 3-iodothyronamine (3-T
Li ZM; Miller M; Gachkar S; Mittag J; Schriever SC; Pfluger PT; Schramm KW; De Angelis M
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1165():122553. PubMed ID: 33503577
[TBL] [Abstract][Full Text] [Related]
19. Substantial impact of 3-iodothyronamine (T1AM) on the regulations of fluorescent thermoprobe-measured cellular temperature and natriuretic peptide expression in cardiomyocytes.
Takahashi H; Nagoshi T; Kimura H; Tanaka Y; Yasutake R; Oi Y; Yoshii A; Tanaka TD; Kashiwagi Y; Yoshimura M
Sci Rep; 2022 Jul; 12(1):12740. PubMed ID: 35882940
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction.
Weil J; Zolk O; Griepentrog J; Wenzel U; Zimmermann WH; Eschenhagen T
Cardiovasc Res; 2006 Feb; 69(2):412-22. PubMed ID: 16376326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
